-
1
-
-
0032941343
-
Cancer risk in mutation carriers of DNA-mismatch-repair genes
-
Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomäki P, Mecklin JP, Järvinen HJ. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-18.
-
(1999)
Int J Cancer
, vol.81
, pp. 214-218
-
-
Aarnio, M.1
Sankila, R.2
Pukkala, E.3
Salovaara, R.4
Aaltonen, L.A.5
de la Chapelle, A.6
Peltomäki, P.7
Mecklin, J.P.8
Järvinen, H.J.9
-
2
-
-
44949202465
-
The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome
-
Watson P, Vasen HF, Mecklin JP, Bernstein I, Aarnio M, Järvinen HJ, Myrhøj T, Sunde L, Wijnen JT, Lynch HT. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 2008;123:444-9.
-
(2008)
Int J Cancer
, vol.123
, pp. 444-449
-
-
Watson, P.1
Vasen, H.F.2
Mecklin, J.P.3
Bernstein, I.4
Aarnio, M.5
Järvinen, H.J.6
Myrhøj, T.7
Sunde, L.8
Wijnen, J.T.9
Lynch, H.T.10
-
3
-
-
56649118678
-
Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families
-
Boilesen AE, Bisgaard ML, Bernstein I. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families. Acta Obstet Gynecol Scand 2008;87:1129-35.
-
(2008)
Acta Obstet Gynecol Scand
, vol.87
, pp. 1129-1135
-
-
Boilesen, A.E.1
Bisgaard, M.L.2
Bernstein, I.3
-
4
-
-
0034897120
-
International Collaborative Group on HNPCC. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer
-
Watson P, Bützow R, Lynch HT, Mecklin JP, Järvinen HJ, Vasen HF, Madlensky L, Fidalgo P, Bernstein I. International Collaborative Group on HNPCC. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 2001;82:223-8.
-
(2001)
Gynecol Oncol
, vol.82
, pp. 223-228
-
-
Watson, P.1
Bützow, R.2
Lynch, H.T.3
Mecklin, J.P.4
Järvinen, H.J.5
Vasen, H.F.6
Madlensky, L.7
Fidalgo, P.8
Bernstein, I.9
-
5
-
-
29144481733
-
Survival of patients with ovarian cancer due to a mismatch repair defect
-
Crijnen TE, Janssen-Heijnen ML, Gelderblom H, Morreau J, Nooij MA, Kenter GG, Vasen HF. Survival of patients with ovarian cancer due to a mismatch repair defect. Fam Cancer 2005;4:301-5.
-
(2005)
Fam Cancer
, vol.4
, pp. 301-305
-
-
Crijnen, T.E.1
Janssen-Heijnen, M.L.2
Gelderblom, H.3
Morreau, J.4
Nooij, M.A.5
Kenter, G.G.6
Vasen, H.F.7
-
6
-
-
46449117480
-
Hereditary gynecologic cancers: Differential diagnosis, surveillance, management and surgical prophylaxis
-
Lu KH. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis. Fam Cancer 2008;7:53-8.
-
(2008)
Fam Cancer
, vol.7
, pp. 53-58
-
-
Lu, K.H.1
-
7
-
-
13744255220
-
Surgical prevention of cancer
-
Bertagnolli MM. Surgical prevention of cancer. J Clin Oncol 2005;23:324-32.
-
(2005)
J Clin Oncol
, vol.23
, pp. 324-332
-
-
Bertagnolli, M.M.1
-
8
-
-
51649130200
-
-
Schmeler KM, Lu KH. Gynecologic cancers associated with Lynch syndrome/HNPCC. Clin Transl Oncol 2008;10:313-17.
-
Schmeler KM, Lu KH. Gynecologic cancers associated with Lynch syndrome/HNPCC. Clin Transl Oncol 2008;10:313-17.
-
-
-
-
9
-
-
0035098503
-
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
-
Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001;68:700-10.
-
(2001)
Am J Hum Genet
, vol.68
, pp. 700-710
-
-
Risch, H.A.1
McLaughlin, J.R.2
Cole, D.E.3
Rosen, B.4
Bradley, L.5
Kwan, E.6
Jack, E.7
Vesprini, D.J.8
Kuperstein, G.9
Abrahamson, J.L.10
Fan, I.11
Wong, B.12
Narod, S.A.13
-
10
-
-
0142091570
-
The Norwegian founder mutations in BRCA1: High penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer
-
Heimdal K, Maehle L, Apold J, Pedersen JC, Møller P. The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer. Eur J Cancer 2003;39:2205-13.
-
(2003)
Eur J Cancer
, vol.39
, pp. 2205-2213
-
-
Heimdal, K.1
Maehle, L.2
Apold, J.3
Pedersen, J.C.4
Møller, P.5
-
11
-
-
69749116285
-
Screening for familial ovarian cancer: Poor survival of BRCA1/2 related cancers
-
doi:10.1136/jmg.2008.058248
-
Evans GR, Gaarenstroom KN, Stirling D, Shenton A, Maehle L, Dørum A, Steel M, Lalloo F, Apold J, Porteous M, Vasen HF, van Asperen C, Moller P. Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers. J Med Genet 2008;15. doi:10.1136/jmg.2008.058248.
-
J Med Genet
, vol.2008
, Issue.15
-
-
Evans, G.R.1
Gaarenstroom, K.N.2
Stirling, D.3
Shenton, A.4
Maehle, L.5
Dørum, A.6
Steel, M.7
Lalloo, F.8
Apold, J.9
Porteous, M.10
Vasen, H.F.11
van Asperen, C.12
Moller, P.13
-
12
-
-
77349118457
-
-
Cancer Registry of Norway. Long-term cancer survival: patterns and trends in Norway 1965-2007. In: Cancer in Norway 2007. Cancer incidence, mortality, survival and prevalence in Norway Oslo, 2008:17.
-
Cancer Registry of Norway. Long-term cancer survival: patterns and trends in Norway 1965-2007. In: Cancer in Norway 2007. Cancer incidence, mortality, survival and prevalence in Norway Oslo, 2008:17.
-
-
-
-
14
-
-
58149347689
-
High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers
-
Maehle L, Apold J, Paulsen T, Hagen B, Løvslett K, Fiane B, Van Ghelue M, Clark N, Møller P. High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers. Clin Cancer Res 2008;14:7569-73.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 7569-7573
-
-
Maehle, L.1
Apold, J.2
Paulsen, T.3
Hagen, B.4
Løvslett, K.5
Fiane, B.6
Van Ghelue, M.7
Clark, N.8
Møller, P.9
-
15
-
-
2142810969
-
Biology of epithelial ovarian cancer: Implications for screening women at high genetic risk
-
Hogg R, Friedlander M. Biology of epithelial ovarian cancer: implications for screening women at high genetic risk. J Clin Oncol 2004;22:1315-27.
-
(2004)
J Clin Oncol
, vol.22
, pp. 1315-1327
-
-
Hogg, R.1
Friedlander, M.2
|